179 related articles for article (PubMed ID: 9860406)
1. Retinal complications and plasma C5a levels during interferon alpha therapy for chronic hepatitis C.
Sugano S; Suzuki T; Watanabe M; Ohe K; Ishii K; Okajima T
Am J Gastroenterol; 1998 Dec; 93(12):2441-4. PubMed ID: 9860406
[TBL] [Abstract][Full Text] [Related]
2. Retinal complications with elevated circulating plasma C5a associated with interferon-alpha therapy for chronic active hepatitis C.
Sugano S; Yanagimoto M; Suzuki T; Sato M; Onmura H; Aizawa H; Makino H
Am J Gastroenterol; 1994 Nov; 89(11):2054-6. PubMed ID: 7942735
[TBL] [Abstract][Full Text] [Related]
3. Risk factors for retinopathy associated with interferon alpha-2b and ribavirin combination therapy in patients with chronic hepatitis C.
Okuse C; Yotsuyanagi H; Nagase Y; Kobayashi Y; Yasuda K; Koike K; Iino S; Suzuki M; Itoh F
World J Gastroenterol; 2006 Jun; 12(23):3756-9. PubMed ID: 16773695
[TBL] [Abstract][Full Text] [Related]
4. Retinal complications during interferon therapy for chronic hepatitis C.
Kawano T; Shigehira M; Uto H; Nakama T; Kato J; Hayashi K; Maruyama T; Kuribayashi T; Chuman T; Futami T; Tsubouchi H
Am J Gastroenterol; 1996 Feb; 91(2):309-13. PubMed ID: 8607498
[TBL] [Abstract][Full Text] [Related]
5. Does ascorbic acid prevent retinopathy during interferon therapy in patients with chronic hepatitis C?
Nishiguchi S; Shiomi S; Enomoto M; Lee C; Jomura H; Tamori A; Habu D; Takeda T; Yanagihara N; Shiraki K
J Gastroenterol; 2001 Jul; 36(7):486-91. PubMed ID: 11480793
[TBL] [Abstract][Full Text] [Related]
6. Vogt-Koyanagi-Harada disease occurring during interferon alpha therapy for chronic hepatitis C.
Kasahara A; Hiraide A; Tomita N; Iwahashi H; Imagawa A; Ohguro N; Yamamoto S; Mita E; Hayashi N
J Gastroenterol; 2004 Nov; 39(11):1106-9. PubMed ID: 15580406
[TBL] [Abstract][Full Text] [Related]
7. [Interferon dysoric retinopathy in chronic viral hepatitis C: case report and literature review].
Naïja N; Mohsni B; Belkahla N; Maamouri N; Ben Mami N
Rev Med Interne; 2014 Aug; 35(8):543-5. PubMed ID: 24182682
[TBL] [Abstract][Full Text] [Related]
8. [Reversible Perimacular Retinopathy by Long-Time Interferon alpha Therapy].
Sandner D; Pillunat LE
Klin Monbl Augenheilkd; 2004 Jan; 221(1):63-6. PubMed ID: 14745683
[TBL] [Abstract][Full Text] [Related]
9. Is screening for interferon retinopathy in hepatitis C justified?
Cuthbertson FM; Davies M; McKibbin M
Br J Ophthalmol; 2004 Dec; 88(12):1518-20. PubMed ID: 15548803
[TBL] [Abstract][Full Text] [Related]
10. Posterior segment complications in patients with hepatitis C treated with interferon and ribavirin.
Schulman JA; Liang C; Kooragayala LM; King J
Ophthalmology; 2003 Feb; 110(2):437-42. PubMed ID: 12578794
[TBL] [Abstract][Full Text] [Related]
11. [Interferon-induced retinal changes].
Chuman T; Nao-i N; Sawada A; Kawano T; Shigehira M
Nippon Ganka Gakkai Zasshi; 1994 Jun; 98(6):616-21. PubMed ID: 7518188
[TBL] [Abstract][Full Text] [Related]
12. Interferon-associated retinopathy in a uniform regimen of natural interferon-alpha therapy for chronic hepatitis C.
Saito H; Ebinuma H; Nagata H; Inagaki Y; Saito Y; Wakabayashi K; Takagi T; Nakamura M; Katsura H; Oguchi Y; Ishii H
Liver; 2001 Jun; 21(3):192-7. PubMed ID: 11422782
[TBL] [Abstract][Full Text] [Related]
13. Interferon-antibodies and the breakthrough phenomenon during ribavirin/interferon-alpha combination therapy and interferon-alpha monotherapy of patients with chronic hepatitis C.
Hoffmann RM; Berg T; Teuber G; Prümmer O; Leifeld L; Jung MC; Spengler U; Zeuzem S; Hopf U; Pape GR
Z Gastroenterol; 1999 Aug; 37(8):715-23. PubMed ID: 10494606
[TBL] [Abstract][Full Text] [Related]
14. Retinal vascular complications associated with interferon-ribavirin therapy for chronic hepatitis C: A population-based study.
Lai CH; Yang YH; Chen PC; King YC; Liu CY
Pharmacoepidemiol Drug Saf; 2018 Feb; 27(2):191-198. PubMed ID: 29210149
[TBL] [Abstract][Full Text] [Related]
15. Natural interferon therapy: optic nerve ischemic damage?
Norcia F; Di Maria A; Prandini F; Redaelli C
Ophthalmologica; 1999; 213(5):339-40. PubMed ID: 10516525
[TBL] [Abstract][Full Text] [Related]
16. Optic disk edema with cotton-wool spots.
Wall M
Surv Ophthalmol; 1995; 39(6):502-8. PubMed ID: 7660303
[TBL] [Abstract][Full Text] [Related]
17. Ocular complications with high-dose interferon alpha in chronic active hepatitis.
Kadayifcilar S; Boyacioglu S; Kart H; Gursoy M; Aydin P
Eye (Lond); 1999 Apr; 13 ( Pt 2)():241-6. PubMed ID: 10450390
[TBL] [Abstract][Full Text] [Related]
18. Cotton-wool spots and retinal hemorrhages. Interferon-associated retinopathy.
Andreoli MT; Lim JI
JAMA Ophthalmol; 2014 Apr; 132(4):503-4. PubMed ID: 24723156
[No Abstract] [Full Text] [Related]
19. Ophthalmologic side effects during alpha-interferon therapy for viral hepatitis.
d'Alteroche L; Majzoub S; Lecuyer AI; Delplace MP; Bacq Y
J Hepatol; 2006 Jan; 44(1):56-61. PubMed ID: 16223542
[TBL] [Abstract][Full Text] [Related]
20. Interferon-alpha-2B and ribavirin in combination for chronic hepatitis C patients not responding to interferon-alpha alone: an Italian multicenter, randomized, controlled, clinical study.
Barbaro G; Di Lorenzo G; Soldini M; Giancaspro G; Bellomo G; Belloni G; Grisorio B; Annese M; Bacca D; Francavilla R; Rizzo G; Barbarini G
Am J Gastroenterol; 1998 Dec; 93(12):2445-51. PubMed ID: 9860407
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
